Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model.

British journal of cancer

Volumn 110, Issue 8, 2014, Pages 2090-2098

  Fox, R ^a   Berhane, S ^a   Teng, M ^b   Cox, T ^a   Tada, T ^a   Toyoda, H ^a   Kumada, T ^a   Kagebayashi, C ^a   Satomura, S ^a   Johnson, P J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFP PROTEIN, HUMAN; ALPHA FETOPROTEIN; BILIRUBIN; BIOLOGICAL MARKER; DECARBOXYPROTHROMBIN; PROTEIN PRECURSOR; PROTHROMBIN; SERUM ALBUMIN; TUMOR MARKER;

AGED; ARTICLE; BLOOD; FEMALE; GENETICS; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; UNITED KINGDOM;

AGED; ALPHA-FETOPROTEINS; BILIRUBIN; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; GREAT BRITAIN; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; SERUM ALBUMIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84901840682     PISSN: None     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.130     Document Type: Article

References (0)